Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2011 AL 2025

Cognitive heterogeneity in Parkinson's disease: A mechanistic view

Carceles-Cordon M, Weintraub D, Chen-Plotkin AS.

Neuron. 2023 May 17;111(10):1531-1546. doi: 10.1016/j.neuron.2023.03.021. Epub 2023 Apr 6.

X-linked hydrocephalus genes: Their proximity to telomeres and high A + T content compared to Parkinson's disease

Hart M, Conrad J, Barrett E, Legg K, Ivey G, Lee PHU, Yung YC, Shim JW.

Exp Neurol. 2023 Aug;366:114433. doi: 10.1016/j.expneurol.2023.114433. Epub 2023 May 6.

Abnormal eye movements in Parkinson's disease: From experimental study to clinical application

Li H, Zhang X, Yang Y, Xie A.

Parkinsonism Relat Disord. 2023 Oct;115:105791. doi: 10.1016/j.parkreldis.2023.105791. Epub 2023 Jul 29.

Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease

Cao R, Chen C, Wen J, Zhao W, Zhang C, Sun L, Yuan L, Wu C, Shan L, Xi M, Sun H.

Bioorg Chem. 2023 Dec;141:106906. doi: 10.1016/j.bioorg.2023.106906. Epub 2023 Oct 7.

A review of emergent intelligent systems for the detection of Parkinson's disease

Dhanalakshmi S, Maanasaa RS, Maalikaa RS, Senthil R.

Biomed Eng Lett. 2023 Sep 20;13(4):591-612. doi: 10.1007/s13534-023-00319-2. eCollection 2023 Nov.

Elucidating distinct molecular signatures of Lewy body dementias

Harvey J, Pishva E, Chouliaras L, Lunnon K.

Neurobiol Dis. 2023 Nov;188:106337. doi: 10.1016/j.nbd.2023.106337. Epub 2023 Oct 31.

Clinical biomarkers for Lewy body diseases

Abdelmoaty MM, Lu E, Kadry R, Foster EG, Bhattarai S, Mosley RL, Gendelman HE.

Cell Biosci. 2023 Nov 14;13(1):209. doi: 10.1186/s13578-023-01152-x.

Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target

Mitra R, Premraj L, Khoo TK.

Parkinsonism Relat Disord. 2023 Jul;112:105448. doi: 10.1016/j.parkreldis.2023.105448. Epub 2023 May 19.

Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders

Kargbo RB.

ACS Med Chem Lett. 2023 Mar 16;14(4):367-368. doi: 10.1021/acsmedchemlett.3c00077. eCollection 2023 Apr 13.

Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms

Huang P, Zhang LY, Tan YY, Chen SD.

Transl Neurodegener. 2023 Jan 30;12(1):5. doi: 10.1186/s40035-023-00337-1.

Parkinson's disease and cardiovascular involvement: Edifying insights (Review)

Grosu L, Grosu AI, Crisan D, Zlibut A, Perju-Dumbrava L.

Biomed Rep. 2023 Feb 14;18(3):25. doi: 10.3892/br.2023.1607. eCollection 2023 Mar.

Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview

Yahya V, Di Fonzo A, Monfrini E.

Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.

The role of wrist-worn technology in the management of Parkinson's disease in daily life: A narrative review

Li P, van Wezel R, He F, Zhao Y, Wang Y.

Front Neuroinform. 2023 Apr 12;17:1135300. doi: 10.3389/fninf.2023.1135300. eCollection 2023.

The heterogeneity of Parkinson's disease

Wüllner U, Borghammer P, Choe CU, Csoti I, Falkenburger B, Gasser T, Lingor P, Riederer P.

J Neural Transm (Vienna). 2023 Jun;130(6):827-838. doi: 10.1007/s00702-023-02635-4. Epub 2023 May 11.

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson's Disease

Martinez-Nunez AE, LeWitt PA.

J Parkinsons Dis. 2023;13(4):441-451. doi: 10.3233/JPD-230055.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias